Hara, A., Koyama-Nasu, R., Takami, M., Toyoda, T., Aoki, T., Ihara, F., . . . Motohashi, S. (2020). CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy. Cancer Immunol Immunother.
Citação norma ChicagoHara, Ayaka, et al. "CD1d Expression in Glioblastoma Is a Promising Target for NKT Cell-based Cancer Immunotherapy." Cancer Immunol Immunother 2020.
MLA CitationHara, Ayaka, et al. "CD1d Expression in Glioblastoma Is a Promising Target for NKT Cell-based Cancer Immunotherapy." Cancer Immunol Immunother 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.